Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by DSMed77on Feb 27, 2021 8:16am
240 Views
Post# 32678268

RE:RE:How much are ppl willing to sell if this goes to the moon??

RE:RE:How much are ppl willing to sell if this goes to the moon??
PTBailey wrote: I have been in this stock for a couple of yrs. I would consider selling varies amounts at different price points. I orignially bought in at .28 cents and eventually leveraged down to an average of .04. Currently have 1.3 mil shares. First sell point for me is .15 and sell enought to recover my costs.


100% agree here.  I also bought a few years ago with an average at 0.04.  I plan on selling 1/3 of my holdings at 0.12 for a 300% gain which would also be my initial investment covered.  Afterwards holding onto the other 2/3 of my shares (riding it for free) to who knows where.  1?  2?  5?  At that point it doesnt matter because my initial investment is secure.  Invest smartly.  GL All.  

Goooooo  KLY

<< Previous
Bullboard Posts
Next >>